Huysman, M.W.

infant level preterm infants growth study treatment preterm serum hospitalisation cortisol dexa treatment weight children birth immunisation effect igf-i igfbp month patient birth weight serum gh levels bronchopulmonary dysplasia group 12 months baseline v јmaxfrc igfbp -3 levels pediatr baseline cortisol levels ventilation score pediatrics result analysis lung disease function signi signi ficantly hospitalisation costs hormone z score јmaxfrc disease head circumference dexamethasone palivizumab cortisol levels cost-effectiveness period measurement netherland gh treatment length bronchopulmonary crown-heel length knee-heel length dysplasia rotterdam reference case reference outcome lung function syncytial serum igf-i serum igf-i levels birth weight infants administration virus protein nonventilated infants child endocrinol hospitalisation risk serum igfbp increase 17 ohp levels difference placebo syncytial virus